Actively Recruiting
Randomized Study of Weekly Petrelintide Injections Versus Placebo for Weight Management in Adults With Overweight or Obesity and Cardiovascular Disease
Led by Hoffmann-La Roche · Updated on 2026-10-07
2500
Participants Needed
3
Research Sites
10 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of petrelintide compared to a placebo in adults who have overweight or obesity along with established cardiovascular disease. This Phase III study aims to understand how petrelintide, combined with a reduced-calorie diet and increased physical activity, may help manage weight in this population. Participants will receive either petrelintide or a matching placebo, both given as weekly subcutaneous injections using a drug-device combination product. The study follows a randomized, double-blind, placebo-controlled, parallel-group design, with treatment continuing up to 64 weeks. Both groups will also follow a reduced-calorie diet and increase physical activity during the trial. Throughout the study, participants will undergo regular assessments including measurements of body weight, waist circumference, blood tests for cholesterol and glucose levels, as well as questionnaires on quality of life and physical functioning. Researchers will monitor changes from baseline to week 64 and track any adverse events. The total participation duration spans the 64-week treatment period with ongoing monitoring of safety and effectiveness measures.
CONDITIONS
Brief Title
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
Research Team
R
Reference Study ID Number: CC46446 https://forpatients.roche.com/No attachments to email below.
F
Fastest Response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here